171 results on '"Biswas, Kaustav"'
Search Results
2. Establishment of a 96-well transwell system using primary human gut organoids to capture multiple quantitative pathway readouts
3. Peptide Drug DiscoveryRaison d’Etre: Engineering Mindset, Design Rules and Screening Tools
4. Rapid label-free cell-based Approach Membrane Permeability Assay using MALDI-hydrogen-deuterium exchange mass spectrometry for peptides
5. Design-Rules for Stapled Alpha-Helical Peptides with On-Target In Vivo Activity: Application to Mdm2/X dual antagonists
6. Development of a high-throughput barrier function assay using primary human gut organoids
7. Preface
8. Accelerated Identification of Cell Active KRAS Inhibitory Macrocyclic Peptides using Mixture Libraries and Automated Ligand Identification System (ALIS) Technology
9. Parallel Synthesis and Screening of a Solid Phase Carbohydrate Library
10. Discovery of cell active macrocyclic peptides with on-target inhibition of KRAS signaling
11. NanoClick: A High Throughput, Target-Agnostic Peptide Cell Permeability Assay
12. Peptide Drug Discovery Raison d'Etre: Engineering Mindset, Design Rules and Screening Tools.
13. Total syntheses of [17]- and [18]dehydrodesoxyepothilones B via a concise ring-closing metathesis-based strategy: correlation of ring size with biological activity in the epothilone series
14. Highly concise routes to epothilones: The total synthesis and evaluation of epothilone 490
15. 4 Small Molecule Bradykinin B1 Receptor Antagonists as Potential Therapeutic Agents for Pain
16. Use of Cryopreserved Hepatocytes as Part of an Integrated Strategy to Characterize In Vivo Clearance for Peptide-Antibody Conjugate Inhibitors of Nav1.7 in Preclinical Species
17. Engineering NaV1.7 Inhibitory JzTx-V Peptides with a Potency and Basicity Profile Suitable for Antibody Conjugation To Enhance Pharmacokinetics
18. Peptide-Membrane Interactions Affect the Inhibitory Potency and Selectivity of Spider Toxins ProTx-II and GpTx-1
19. Discovery of Tarantula Venom-Derived NaV1.7-Inhibitory JzTx-V Peptide 5-Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis
20. Engineering Antibody Reactivity for Efficient Derivatization to Generate NaV1.7 Inhibitory GpTx-1 Peptide–Antibody Conjugates
21. Discovery of TRPM8 Antagonist (S)-6-(((3-Fluoro-4-(trifluoromethoxy)phenyl)(3-fluoropyridin-2-yl)methyl)carbamoyl)nicotinic Acid (AMG 333), a Clinical Candidate for the Treatment of Migraine
22. Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V
23. Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction
24. Synthesis of Epothilone Analogs: Toward the Development of Potent Anticancer Drugs
25. Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1
26. Engineering Antibody Reactivity for Efficient Derivatization to Generate NaV1.7 Inhibitory GpTx-1 Peptide–Antibody Conjugates
27. Peptide-Membrane Interactions Affect the Inhibitory Potency and Selectivity of Spider Toxins ProTx-II and GpTx‑1.
28. Discovery of Tarantula Venom-Derived NaV1.7-Inhibitory JzTx‑V Peptide 5‑Br-Trp24 Analogue AM-6120 with Systemic Block of Histamine-Induced Pruritis.
29. Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer’s disease
30. Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1
31. Sustained inhibition of the Na V 1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1
32. Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V.
33. Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency
34. Chromenones as potent bradykinin B1 antagonists
35. Motion Control Strategies based on PD Control for a Four Degree-of-Freedom Serial Robotic Manipulator to Mimic Human Index Finger Articulations
36. 3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation
37. Aryl sulfonamides containing tetralin allylic amines as potent and selective bradykinin B1 receptor antagonists
38. Unfolded Protein Response in Cancer: IRE1α Inhibition by Selective Kinase Ligands Does Not Impair Tumor Cell Viability
39. Discovery of Clinical Candidate 1-(4-(3-(4-(1H-Benzo[d]imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)ethanone (AMG 579), A Potent, Selective, and Efficacious Inhibitor of Phosphodiesterase 10A (PDE10A)
40. HEAD AND NECK MALIGNANCY IN YOUNG FEMALES - OUR EXPERIENCE
41. Aryl sulfones as novel Bradykinin B1 receptor antagonists for treatment of chronic pain
42. Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1.
43. Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists
44. Discovery of novel hydroxy-thiazoles as HIF-α prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation
45. Discovery of Potent, Orally Bioavailable Phthalazinone Bradykinin B1 Receptor Antagonists
46. ChemInform Abstract: Highly Concise Routes to Epothilones: The Total Synthesis and Evaluation of Epothilone 490.
47. Editorial [Hot Topic:New Approaches for the Treatment of Pain and Inflammation (Guest Editor: Kaustav Biswas)]
48. Potent Nonpeptide Antagonists of the Bradykinin B1 Receptor: Structure−Activity Relationship Studies with Novel Diaminochroman Carboxamides
49. Identification of a Nonpeptidic and Conformationally Restricted Bradykinin B1 Receptor Antagonist with Anti-Inflammatory Activity
50. A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.